Brazilian Journal of Anesthesiology
https://app.periodikos.com.br/journal/rba/article/doi/10.1590/S0034-70942008000500003
Brazilian Journal of Anesthesiology
Scientific Article

Transfusão sangüínea no intra-operatório, complicações e prognóstico

Complications and prognosis of intraoperative blood transfusion

João Manoel Silva Junior; Thiago Abreu Cezario; Diogo O. Toledo; Danielle Dourado Magalhães; Marco Aurélio Cícero Pinto; Luiz Gustavo F. Victoria

http://dx.doi.org/10.1590/S0034-70942008000500003 Braz J Anesthesiol, vol.58, n5, p.447-461, 2008
PDF Português
PDF English
Downloads: 1
Views: 1243

Resumo

JUSTIFICATIVA E OBJETIVOS: Transfusões sangüíneas no intra-operatório estão associadas a aumento de complicações no pós-operatório e custos hospitalares. Portanto, este estudo avaliou as características, complicações e possíveis fatores de riscos para morte em pacientes cirúrgicos que necessitaram de transfusões sangüíneas no intra-operatório. MÉTODO: Coorte prospectiva, durante período de um ano, no centro cirúrgico de hospital terciário. Incluíram-se pacientes com idade acima de 18 anos que necessitaram de transfusões sangüíneas no intra-operatório. Testemunhas de Jeová, pacientes que receberam transfusões prévias, falência coronariana e lesão encefálica aguda foram excluídos. RESULTADOS: O estudo envolveu 80 pacientes, com idade média de 68,4 ± 14,1 anos. Os pacientes ASA II foram prevalentes com 69,6% dos casos, os escores APACHE II e POSSUM foram em média, respectivamente, 13,6 ± 4,4 e 37,5 ± 11,4. A hemoglobina média no momento da transfusão era 8,2 ± 1,8 g.dL-1 e 19% dos pacientes apresentavam hemoglobina maior que 10 g.dL-1. Os pacientes receberam em média 2,2 ± 0,9 UI de concentrados de hemácias. A mortalidade hospitalar foi 26,3%. As complicações pós-transfusões totalizaram 57,5% dos casos no pós-operatório e a mais freqüente foi infecção. Foram fatores independentes de morte na regressão logística os escores APACHE II (OR = 1,34; IC 95% 1,102 - 1,622), POSSUM (OR = 1,08; IC 95% 1,008 - 1,150) e número de unidades de concentrados de hemácias recebidas (OR = 2,22; IC 95% 1,100 - 4,463). Quanto maior o número de transfusões sangüíneas, maiores as incidências de complicações e mortalidade. CONCLUSÕES: O valor de hemoglobina e o número de unidades de concentrados de hemácias utilizados foram elevados comparados com os estudos que preconizam estratégias restritivas. Foi encontrada nesta amostra alta incidência de complicações, principalmente infecções, e elevada mortalidade. Os escores APACHE II, POSSUM e maior número de transfusões foram fatores de riscos independentes de pior prognóstico no pós-operatório.

Palavras-chave

COMPLICAÇÕES, SANGUE, SANGUE

Abstract

BACKGROUND AND OBJECTIVES: Intraoperative blood transfusions are associated with an increase in postoperative complications and hospital costs. Thus, this study evaluated the characteristics, complications, and probable risk factors for death in surgical patients who needed intraoperative blood transfusions. METHODS: This is a prospective study that spanned a one-year period, undertaken at the surgical suite of a tertiary hospital. Patients older than 18 years who needed intraoperative blood transfusions were included in this study. Jehovah witnesses, patients with a history of prior blood transfusions, coronary failure, and acute brain lesions were excluded. RESULTS: Eighty patients with mean age of 68.4 ± 14.1 years participated in the study. Most patients were ASA II, representing 69.6% of the study group; APACHE and POSSUM scores were 13.6 ± 4.4 and 37.5 ± 11.4, respectively. Mean hemoglobin at the time of transfusion was 8.2 ±1.8 g.dL-1 and 19% of the patients had hemoglobin levels higher than 10 g.dL-1. Patients received an average of 2.2 ± 0.9 IU of packed red blood cells. Hospital mortality was 26.3%. Post-transfusion complications totaled 57.5% of the cases in the postoperative period, and most of them were due to infections. In the logistic regression, independent factors for death included APACHE II (OR = 1.34; 95% CI 1.102-1.622), POSSUM (OR = 1.08; 95% CI 1.008-1.150) and the number of packed red blood cells received (OR = 2.22; 95% CI 1.100-4.463). Thus, the higher the number of transfusions, the greater the incidence of complications and mortality. CONCLUSIONS: Hemoglobin level, and the number of packed red blood cells used were elevated when compared with studies that suggest restrictive strategies. This sample presented a high incidence of complications, especially infections, and complications. APACHE II and POSSUM scores and the number of transfusions were independent risk factors for a worse postoperative prognosis.

Keywords

BLOOD, BLOOD, COMPLICATIONS

Referências

Whitaker B, Sullivan M. The 2005 Nationwide Blood Collection and Utilization Survey Report. 2006.

Park KW, Chandhok D. Transfusion-associated complications. Int Anesthesiol Clin. 2004;42:11-26.

Robinson WP III, Ahn J, Stiffler A. Blood transfusion is an independent predictor of increased mortality in nonoperatively managed blunt hepatic and splenic injuries. J Trauma. 2005;58:437-444.

Taylor RW, Manganaro L, O'Brien J. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med. 2002;30:2249-2254.

Koch CG, Li L, Duncan AI. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006;34:1608-1616.

Koch CG, Li L, Van Wagoner DR. Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg. 2006;82:1747-1756.

Hébert PC, Wells G, Tweeddale M. Does transfusion practice affect mortality in critically ill patients?. Am J Respir Crit Care Med. 1997;155:1618-1623.

Taylor RW, Manganaro L, O'Brien J. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med. 2002;30:2249-2254.

Russell JA, Phang PT. The oxygen delivery/consumption controversy: an approach to management of the critically ill. Am J Respir Crit Care Med. 1994;149:533-537.

Herbert PC, Wells G, Blajchman MA. A multicenter, randomized, controlled clinical trial of transfusion requiremente in critical care. N Engl J Med. 1999;340:409-17.

Vincent JL, Baron JF, Reinhart K. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288:1499-1507.

Knaus WA, Draper EA, Wagner DP. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.

Vincent JL, de Mendonca A, Cantraine F. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems of the European Society of Intensive Care Medicine". Crit Care Med. 1998;26:1793-1800.

Marshall JC, Cook DJ, Christou NV. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23:1638-1652.

Copeland GP, Jones D, Walters M. POSSUM: a scoring system for surgical audit. Br J Surg. 1991;78:355-360.

Anon . New classification of physical status. Anesthesiology. 1963;24:111.

Weil MH, Afifi AA. Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation. 1970;41:989-1001.

Smith l, Kumar P, Molloy S. Base excess and lactate as prognostic indicators for patients admitted to intensive care. Intensive Care Med. 2001;7:204-211.

Rivers E, Nguyen B, Havstad S. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368-1377.

Meregalli A, Oliveira RP, Friedman G. Occult hypoperfusion is associated with increased mortality in hemodynamically stable, highrisk, surgical patients. Crit Care. 2004;8:R60-R65.

Mekontso-Dessap A, Castelain V, Anguel N. Combination of venoarterial PCO2 difference with arteriovenous O2 content difference to detect anaerobic metabolism in patients. Intensive Care Med. 2002;28:272-277.

Goodnough LT. Risks of blood transfusion. Crit Care Med. 2003;31:S678-S686.

Dellinger RP, Carlet JM, Masur H. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32:858-873.

Weiskopf RB, Viele MK, Feiner J. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA. 1998;279:217-221.

Howell PJ, Bamber PA. Severe acute anaemia in a Jehovah's Witness: Survival without blood transfusion. Anaesthesia. 1987;42:44-48.

Chernow B. Blood conservation in critical care: the evidence accumulates. Crit Care Med. 1993;21:481-482.

Foulke GE, Harlow DJ. Effective measures for reducing blood loss from diagnostic laboratory tests in intensive care unit patients. Crit Care Med. 1989;17:1143-1145.

5dd6a2b80e8825162c13f286 rba Articles
Links & Downloads
2352-2291 (Eletrônico) 0104-0014 (Impresso)
Braz J Anesthesiol ©2024 Todos os direitos reservados.

Braz J Anesthesiol

Share this page
Page Sections